Similar Articles
1311 High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation
1312 Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma
1313 Hepatocellular carcinoma: Review of disease and tumor biomarkers
1314 Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma
1315 Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein
1316 Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma
1317 New advances in hepatocellular carcinoma
1318 Preoperative portal vein embolization for hepatocellular carcinoma: Consensus and controversy
1319 Latest developments in precancerous lesions of hepatocellular carcinoma
1320 Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA